Impact of a pharmaceutical care program on liver transplant patients? compliance with immunosuppressive medication - A prospective, randomized, controlled trial using electronic monitoring

Not Applicable

Completed

• Conditions: iver transplants; Injury, Occupational Diseases, Poisoning; Liver transplants

• Registration Number: ISRCTN83224156
• Lead Sponsor: niversity Hospital Mainz, Pharmacy Department (Germany)

Brief Summary

2009 results in https://pubmed.ncbi.nlm.nih.gov/19300186/ (added 10/06/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-03-30
• Study Start: 2007-10-30
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Written informed consent
2. Age 18 years or older
3. First organ transplant
4. Follow-up care at the University Hospital Mainz for the first year after transplantation
5. Administration of oral immunosuppressive therapy as capsule or tablet
6. Literacy (German language)

Exclusion Criteria

Patients who are not willing to use the Medication Event Monitoring Systems® (MEMS®)

Study & Design

• Study Type: Interventional
• Study Design: Not specified